EA7-26266-95673
4 vaccinations
11 coded responses
44 check-ins
10 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 51-55
- ZIP prefix
- 234 / VA
- Registered
- 2021-03-25
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-22
Dose 1 — Pfizer-BioNTech
-
2021-03-25
Registered in v-safe
- 2021-03-25
- 2021-03-26
- 2021-03-27
- 2021-03-28
- 2021-03-29
- 2021-04-05
- 2021-04-12
-
2021-04-13
Dose 2 — Pfizer-BioNTech
-
2021-04-13
Survey response — day 0, dose 2MedDRA: Dizziness, Immediate post-injection reaction — Feeling: GoodFree text: brief lightheadedness during 30min post vaccine observation time. Removing my mask and drinking water made it go away in 5min.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-14
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-04-15
-
2021-04-16
Survey response — days 1–6 daily, dose 2MedDRA: Oropharyngeal pain, Upper-airway cough syndrome — Feeling: Fair · Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: sore throat, nasal dripMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-17
- 2021-04-18
- 2021-04-19
- 2021-04-20
- 2021-04-27
- 2021-05-04
- 2021-05-11
- 2021-05-18
- 2021-05-25
-
2021-07-13
Survey response — 3 months, dose 2MedDRA: Cough, Nausea, Rhinorrhoea, Sneezing — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Runny nose, cough, sneezing and nauseaMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-10-12
-
2021-10-16
Dose 3 — Pfizer-BioNTech
- 2021-10-16
-
2021-10-17
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain, Redness, Swelling · NoneAdult check-in
- 2021-10-18
-
2021-10-19
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Site: Pain · Headache · Be unable to do your normal daily activitiesAdult check-in
- 2021-10-20
- 2021-10-21
- 2021-10-22
- 2021-10-23
- 2021-10-30
- 2021-11-06
-
2021-11-13
Survey response — day 28, dose 3MedDRA: Office visit, Vitreous detachment — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visitFree text: Symptoms: Posterior Vitreous Detachment on 11/7/21. I doubt it's related. · Healthcare visit (other): Ophthalmologist 2 visits and Retina Specialist 1 visitMedDRA releases: 2024-11 · check-in free text available
-
2021-11-13
Report sent to call center — day 28, dose 3Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalEmergency room or emergency department visit · 1 call case(s)
- 2021-11-17
-
2021-11-20
Survey response — day 35, dose 3MedDRA: Migraine — Feeling: Good · Be unable to do your normal daily activitiesFree text: MigraineMedDRA releases: 2024-11 · check-in free text available
-
2021-11-27
Survey response — day 42, dose 3MedDRA: Migraine — Feeling: Good · Be unable to do your normal daily activitiesFree text: MigrainesMedDRA releases: 2024-11 · check-in free text available
-
2022-01-15
Survey response — 3 months, dose 3MedDRA: Cough, Rhinorrhoea, Sneezing — Feeling: FairFree text: Runny nose, sneezing and mild coughMedDRA releases: 2024-11 · check-in free text available
-
2022-04-16
Survey response — 6 months, dose 3MedDRA: Adverse reaction, Fatigue, Migraine — Feeling: Good · Be unable to do your normal daily activitiesFree text: Fatigue, allergy like symptoms, several migrainesMedDRA releases: 2024-11 · check-in free text available
-
2022-07-16
Dose 4 — Pfizer-BioNTech
- 2022-07-30
- 2022-08-06
-
2022-08-13
Survey response — day 28, dose 4MedDRA: Bladder discomfort — Feeling: GoodFree text: Bladder discomfort which isn't a UTI or bladder infection according to tests. The issue probably isn't related to the vaccine.MedDRA releases: 2024-11 · check-in free text available
- 2022-08-20
- 2022-08-27
-
2022-10-15
Survey response — 3 months, dose 4MedDRA: Nephrolithiasis — Feeling: GoodFree text: 2 kidney stonesMedDRA releases: 2024-11 · check-in free text available
-
2023-01-14
Survey response — 6 months, dose 4MedDRA: Cough, Fatigue, Headache, Malaise, Oropharyngeal pain, Productive cough, Pyrexia, Rhinorrhoea — Feeling: Good · Be unable to do your normal daily activitiesMedDRA releases: 2024-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-22 | Pfizer-BioNTech | |
| 2 | 2021-04-13 | Pfizer-BioNTech | |
| 3 | 2021-10-16 | Pfizer-BioNTech | No |
| 4 | 2022-07-16 | Pfizer-BioNTech | No |
Call center
1 call center case
1 unsuccessful
Free text
Release 7 — day 0, dose 2
Systemic reaction (other): brief lightheadedness during 30min post vaccine observation time. Removing my mask and drinking water made it go away in 5min.
Release 7 — days 1–6 daily, dose 2
Systemic reaction (other): sore throat, nasal drip
Release 9 — 3 months, dose 2
Symptoms: Runny nose, cough, sneezing and nausea
Release 10 — day 28, dose 3
Symptoms: Posterior Vitreous Detachment on 11/7/21. I doubt it's related.
Healthcare visit (other): Ophthalmologist 2 visits and Retina Specialist 1 visit
Release 10 — day 35, dose 3
Symptoms: Migraine
Release 10 — day 42, dose 3
Symptoms: Migraines
Release 10 — 3 months, dose 3
Symptoms: Runny nose, sneezing and mild cough
Release 11 — 6 months, dose 3
Symptoms: Fatigue, allergy like symptoms, several migraines
Release 12 — day 28, dose 4
Symptoms: Bladder discomfort which isn't a UTI or bladder infection according to tests. The issue probably isn't related to the vaccine.
Release 12 — 3 months, dose 4
Symptoms: 2 kidney stones
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | · | · | ✓ |
| SD | Adverse reaction | · | · | ✓ |
| SD | Bladder discomfort | · | · | ✓ |
| SD | Cough | ✓ | ✓ | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Malaise | · | · | ✓ |
| SD | Migraine | · | · | ✓ |
| SD | Nausea | ✓ | ✓ | ✓ |
| SD | Nephrolithiasis | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Productive cough | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Rhinorrhoea | ✓ | ✓ | ✓ |
| SD | Sneezing | ✓ | ✓ | ✓ |
| SD | Vitreous detachment | · | · | ✓ |
| SRO | Dizziness | ✓ | ✓ | ✓ |
| SRO | Immediate post-injection reaction | ✓ | ✓ | ✓ |
| SRO | Oropharyngeal pain | ✓ | ✓ | ✓ |
| SRO | Upper-airway cough syndrome | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release